PATENT CLAIM ANALYSIS

Application Number: 16125359
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "264110"]

Abstract:
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Claim (Index 22):
A compound having a structure of formula (II) wherein\n A is independently N or CH;\n W is independently N or CH; \n wherein one or both A and W is N; \n R 1  and R 2  are independently a branched or a linear C 1-6 alkyl; \n R 3  is phenyl substituted by one or two R 5  substituents; \n R 5  is independently selected from one or more halo, \u2014OH, or NH 2 ; and \n R 4  is halo; or \n or a stereoisomer thereof, an atropisomer thereof, a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable salt of the stereoisomer thereof, or a pharmaceutically acceptable salt of the atropisomer thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15093951', '15984855', '15353402', '15805716', '15721021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7559218034379798
- 35 USC 102 Novelty (BERT): 0.5240867070388199
- Combined Prediction Score: 0.7327382937980638
- Mean Citation Score: 287.438
- Max Citation Score: 306.9193
- Similarity Product: 225.59990418543225

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test